ODYSSEY FH I and FH II: Alirocumab Significantly Improves Cholesterol Levels in Patients with HeFH

Article Information

DOI 
http://dx.doi.org/10.1177/155989771427012
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 MD Conference Express®

Author Information

  1. Nicola Parry
  1. Michel Farnier, MD, PhD
    1. Point Medical, Dijon, France
View Full Text

Article usage

AbstractFullPDF
Apr 20151211
May 2015500
Jun 20151711
Jul 20151400
Aug 20155511
Sep 201511300
Oct 2015133
Nov 20151531
Total23297

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
ODYSSEY FH I and FH II: Alirocumab Significantly Improves Cholesterol Levels in Patients with HeFH
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Lipid Disorders
Cardiology Clinical Trials
Cardiology
Lipid Disorders
Cardiology Clinical Trials